维普中文期刊产品整合服务
14篇 您的检索式:作者名="GIAMAS G"
    题名 作者 年代 出处 被引量
1Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models显示文摘AIM To assess the performance of BALAD, BALAD-2 and their component biomarkers in predicting outcome of hepatocellular carcinoma(HCC) patients after liver transplant.METHODS BALAD score and BALAD-2 class are derived from bilirubin, albumin, alpha-fetoprotein(AFP), Lens culinaris agglutinin-reactive AFP(AFP-L3), and des-gammacarboxyprothrombin(DCP). Pre-transplant AFP, AFP-L3 and DCP were measured in 113 patients transplanted for HCC from 2000 to 2008. Hazard ratios(HR) for recurrence and death were calculated. Univariate and multivariate regression analyses were conducted. C-statistics were used to compare biomarker-based to predictive models. RESULTS During a median follow-up of 12.2 years, 38 patients recurred and 87 died. The HRs for recurrence in patients with elevated AFP, AFP-L3, and DCP defined by BALAD cut-off values were 2.42(1.18-5.00), 1.86(0.98-3.52), and 2.83(1.42-5.61), respectively. For BALAD, the HRs for recurrence and death per unit increased score were 1.48(1.15-1.91) and 1.59(1.28-1.97). For BALAD-2, the HRs for recurrence and death per unit increased class were 1.45(1.06-1.98) and 1.38(1.09-1.76). For recurrence prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs. 0.64, 0.61, 0.53, and 0.53 for BALAD, BALAD-2, Milan, and UCSF, respectively. Similarly, for death prediction, the combination of three biomarkers had the highest c-statistic of 0.66 vs 0.65,0.61, 0.52, and 0.50 for BALAD, BALAD-2, Milan, and UCSF. A new model combining biomarkers with tumor size at the time of transplant(S-LAD) demonstrated the highest predictive capability with c-statistics of 0.71 and 0.69 for recurrence and death. CONCLUSION BALAD and BALAD-2 are valid in transplant HCC patients, but less predictive than the three biomarkers in combination or the three biomarkers in combination with maximal tumor diameter(S-LAD).Nicha Wongjarupong Gabriela M Negron-Ocasio Roongruedee Chaiteerakij Benyam D Addissie Essa A Mohamed Kristin C Mara William S Harmsen J Paul Theobald Brian E Peters Joseph G Balsanek Melissa M Ward Nasra H Giama Sudhakar K Venkatesh Denise M Harnois Michael R Charlton Hiroyuki Yamada Alicia Algeciras-Schimnich Melissa R Snyder Terry M Therneau Lewis R Roberts 2018World Journal of Gastroenterology2018,24,12:5
2Casein kinase 1 delta ( CK1 δ) interacts with the SNARE associated protein SNAPIN 显示文摘Wolff S Stoter M Giamas G 2006FEBS Lett2006,580,27:1
3The estrogen receptor- alpha-induced microRNA signature regulates itself and its transcriptional response显示文摘Castellano L Giamas G Jacob J 2009Proc Natl Acad Sci USA2009,106,15:1
4Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer显示文摘Giamas G Filipovic A Jacob J 2011Nat Med2011,17,6:1
5CK1 delta modulates the transcriptional activity of ERalpha via AIB1 in an estrogen-dependent manner and regulates ERalpha-AIB1 interactions显示文摘GIAMAS G CASTELLANO L FENG Q 0,,09:1
6Protein kinases as targets for cancer treatment显示文摘Giamas G Stebbing J Vorgias CE 2007Pharmacogenomics2007,8,8:1
7Kinases as targets in the treatment of solid tumors显示文摘Giamas G Man YL Hirner H 2010Cell Signal2010,22,7:1
8The role of the casein kinase 1(CK1)Family in different signaling pathways linked to cancer development显示文摘KNIPPSCHILD U WOLFF S GIAMAS G 2005Onkologie2005,28,10:1
9Kinases as targets in the treatment of solid tumors 显示文摘GIAMAS G MAN YL HIRNER H 2010Cell Signal2010,22,7:1
10The role ofthe casein kinase 1(CK1)family in different signalingpathways linked to cancer development显示文摘Knippschild U Wolff S Giamas G 2005Onkologie2005,28,10:1
11Kinome screening for regula- tors of the estrogen receptor identifies LMTK3 as a new therapeutic tar- get in breast cancer显示文摘Giamas G Filipovifi A Jacob J 2011Nature Med2011,17,6:1
12The role of the casein kinase 1 (CK1) family in different signaling pathways linked to cancer development显示文摘Knippschild U Wolff S Giamas G 2005Onkologie2005,28,10:1
13The role of the ca- sein kinase I(CK1) family in different signaling pathways linked to cancer development显示文摘Knippschild U Wolff S Giamas G et at 2005Onkologie2005,28,10:1
14The role of the casein kinase 1 ( CK1 ) family in different signaling pathways linked to cancer development 显示文摘KNIPPSCHILD U WOLFF S GIAMAS G 2005Onkologie2005,28,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费